Optimized Antibiotic Therapy in Patients With Subarachnoid Haemorrhage (ES) and Cerebral Haemorrhage (EC) (TANDEM)
Prospective Study Evaluating Plasma Exposure of Optimized Antibiotic Therapy According to TDM in Patients With Subarachnoid Haemorrhage (ES) and Cerebral Haemorrhage (EC)
Sponsor: Azienda Sanitaria-Universitaria Integrata di Udine
Listed as NCT04132115, this observational or N/A phase trial focuses on Intracerebral Hemorrhage and Subarachnoid Hemorrhage and remains ongoing. Sponsored by Azienda Sanitaria-Universitaria Integrata di Udine, it has been updated 7 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Aug 2023 — Jul 2024 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Sep 2021 — Aug 2023 [monthly]
Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Recruiting
▶ Show 2 earlier versions
-
Feb 2020 — Jan 2021 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Nov 2019 — Feb 2020 [monthly]
Not Yet Recruiting
First recorded
Oct 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Azienda Sanitaria-Universitaria Integrata di Udine
For direct contact, visit the study record on ClinicalTrials.gov .